BlackRock Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $192M | Buy |
6,134,970
+72,135
| +1% | +$2.25M | 0.09% | 258 |
|
|
2016
Q3 | $244M | Sell |
6,062,835
-207,969
| -3% | -$8.36M | 0.12% | 198 |
|
|
2016
Q2 | $208M | Buy |
6,270,804
+219,630
| +4% | +$7.3M | 0.11% | 229 |
|
|
2016
Q1 | $178M | Buy |
6,051,174
+31,743
| +0.5% | +$933K | 0.1% | 249 |
|
|
2015
Q4 | $158M | Sell |
6,019,431
-431,793
| -7% | -$11.4M | 0.09% | 256 |
|
|
2015
Q3 | $153M | Sell |
6,451,224
-683,982
| -10% | -$16.2M | 0.09% | 252 |
|
|
2015
Q2 | $169M | Sell |
7,135,206
-380,028
| -5% | -$9.02M | 0.09% | 251 |
|
|
2015
Q1 | $178M | Buy |
7,515,234
+714,402
| +11% | +$17M | 0.1% | 246 |
|
|
2014
Q4 | $144M | Buy |
6,800,832
+427,392
| +7% | +$9.07M | 0.08% | 295 |
|
|
2014
Q3 | $109M | Buy |
6,373,440
+232,794
| +4% | +$3.96M | 0.06% | 358 |
|
|
2014
Q2 | $87.9M | Buy |
6,140,646
+9,516
| +0.2% | +$136K | 0.05% | 410 |
|
|
2014
Q1 | $75.8M | Sell |
6,131,130
-431,436
| -7% | -$5.33M | 0.05% | 430 |
|
|
2013
Q4 | $71.9M | Buy |
6,562,566
+344,124
| +6% | +$3.77M | 0.05% | 433 |
|
|
2013
Q3 | $72.2M | Buy |
6,218,442
+1,403,412
| +29% | +$16.3M | 0.05% | 431 |
|
|
2013
Q2 | $53.9M | Buy |
+4,815,030
| New | +$53.9M | 0.04% | 476 |
|